Cargando...

Differential Toxicities of Tyrosine Kinase Inhibitors in the Management of Metastatic Lung Cancer

INTRODUCTION: Erlotinib and gefitinib are the most commonly used epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) in the treatment of EGFR mutant nonsmall cell lung cancer (NSCLC). Both erlotinib and gefitinib have shown equal efficacy in terms of response rates and overall su...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Indian J Med Paediatr Oncol
Main Authors: Udupa, Karthik S, Rajendranath, Rejiv, Sagar, Tenali, Thomas, Joseph
Formato: Artigo
Idioma:Inglês
Publicado: Medknow Publications & Media Pvt Ltd 2017
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5398099/
https://ncbi.nlm.nih.gov/pubmed/28469331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0971-5851.203502
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!